Alert detail
LCD L36192: MolDX: MGMT Promoter Methylation Analysis — Noridian
What changed
New analysis may impact billing practices and reimbursement rates.
Who’s affected: Oncology billing teams · Effective: August 7, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 3 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.